COVID-19: First Trial of Oxford University’s Vaccine Shows Promising Immune Response
The experimental coronavirus vaccine developed by AstraZeneca in collaboration with Oxford University has shown promising results and produced an immune response in part one of the two-phase clinical trials, a data was released on Monday.